Clinical Trial Update: Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating vorinostat with gemtuzumab ozogamicin in older patients with previously untreated acute myeloid leukemia. The study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)
• Zolinza (vorinostat)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 2 | Status: TERMINATED | Results posted: 2017-06-01